Jan Konecny
Hradec Kralove, KR 50001, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Carltonine B derivatives: Synthesis and structure-activity relationship insights for selective butyrylcholinesterase inhibition.
Journal: Bioorganic chemistry
Published: February 11, 2026
Prophylaxis by a reversible cholinesterase inhibitor and the NMDA receptor antagonist treatment as combinatorial countermeasure against nerve agent poisoning in mice model.
Journal: Chemico-biological interactions
Published: October 16, 2024
Dizocilpine derivatives as neuroprotective NMDA receptor antagonists without psychomimetic side effects.
Journal: European journal of medicinal chemistry
Published: May 31, 2024
Potent and reversible open-channel blocker of NMDA receptor derived from dizocilpine with enhanced membrane-to-channel inhibition.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 12, 2024
A-agents, misleadingly known as "Novichoks": a narrative review.
Journal: Archives of toxicology
Published: July 11, 2023
A Decade of Germananes: Four Approaches to Their Functionalization.
Journal: Inorganic chemistry
Published: July 25, 2022
Neurotoxicity evoked by organophosphates and available countermeasures.
Journal: Archives of toxicology
Published: June 30, 2022
Pursuing the Complexity of Alzheimer's Disease: Discovery of Fluoren-9-Amines as Selective Butyrylcholinesterase Inhibitors and N-Methyl-d-Aspartate Receptor Antagonists.
Journal: Biomolecules
Published: November 25, 2020
Last Updated: 09/26/2026